Baxter International

(BAX)

Financial Overview

Target Price $24

About Baxter International

Baxter International Inc., led by CEO José (Joe) Almeida, is a healthcare company providing renal, hospital, and surgical products globally. It supplies infusion systems, IV solutions, and dialysis equipment to hospitals and patients. Under Almeida, Baxter has streamlined operations and invested in supply chain resilience. The company is focused on innovation in acute care and home therapies. Baxter is a key provider of essential healthcare products and services.

Analyst Forecast

Baxter is repairing its balance sheet and portfolio after operational disruption and divestitures. Essential hospital products provide recurring demand, while inflation, quality issues and supply execution constrain margins. Revenue growth alone is insufficient without stronger cash conversion. Recession has limited effect on core care. Debt reduction and consistent manufacturing performance are prerequisites for a credible recovery.

Analysis by Luigi Wewege

Luigi Wewege

President at Caye International Bank

Luigi Wewege is President of the award-winning Caye International Bank. He is the author of The Digital Banking Revolution, now in its third edition, and of the article “Disruptions and Digital Banking Trends,” published in The Journal of Applied Finance & Banking. Luigi has also co-authored economic research examining the accuracy of credit bureau data, which was presented before the United States Congress. At Caye Bank, his research and strategic insights help guide billions in client portfolio decisions across international markets. Known for his disciplined diversification philosophy, he served as the conceptual architect behind this Portfolio Fit Calculator. He holds an Italian MBA specializing in International Business, and earned his BSBA with a triple major in Finance, International Business, and Management, graduating with Latin Honors from the University of Missouri–St. Louis.

18 years of experience

Should You Buy Baxter International Stock?

This interactive tool helps you determine whether this stock fits into your investment strategy based on your portfolio size, risk tolerance, and allocation preferences.

What this calculator analyzes:

  • Risk compatibility between your profile and this stock
  • Appropriate allocation size for your portfolio
  • Diversification recommendations
  • P/E ratio context and valuation analysis
$1K $10M
1% 100%

⚠️ This tool is for informational purposes only. It does not constitute financial advice. Investing involves risk, including loss of capital. Always consult a licensed financial advisor before making investment decisions.